333

LEVEL BIOTECHNOLOGY INC

No trades
See on Supercharts

3118 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Level Biotechnology, Inc. engages in the provision of biotechnological services. It offers the following business activities: biomedical access products, and preclinical testing service businesses. Its Biomedical Access Products business offers cell culture, immune protein, gene nucleic acids and molecular biology, and instruments and equipment for biomedical research units, hospitals, and biotechnology companies. Its Preclinical Testing Service business provides genetic toxicity, general toxicology, reproductive toxicology, pharmacokinetics, biocompatibility, and heath food safety testing services. The company was founded on December 7, 1989 and is headquartered in New Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

3118 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company